Gary Brecka Longevity: How a Regular Patient Would Get Access

Who Is Gary Brecka and What Does He Actually Claim?

Gary Brecka describes himself as a "human biologist" with a background in actuarial mortality risk modeling for the life-insurance industry. He co-founded 10X Health System alongside entrepreneur Grant Cardone and rose to mainstream visibility through appearances on the Joe Rogan Experience, the Tucker Carlson Network, and a recurring role on the Cardone-produced social media circuit. His core thesis: most chronic disease is not genetic destiny but the downstream result of nutrient deficiencies driven by undetected genetic variants, primarily in the methylation pathway.

He has not published peer-reviewed research under his own name. His claims are disseminated through podcasts, Instagram reels, and 10X Health's direct-to-consumer product line. That context matters when evaluating what he recommends.

The 10X Health Business Model

10X Health sells a proprietary genetic test it calls the "Gene Mutation Panel," along with a supplement line, a hyperbaric oxygen therapy (HBOT) practice in South Florida, and a hydrogen-water device. The company does not publish its internal outcome data publicly, which limits independent verification.

Why He Gained Credibility So Quickly

Brecka's actuarial background gave him a vocabulary that sounds quantitative. His before-and-after stories, including a widely circulated account of UFC fighter Jorge Masvidal and podcaster Tucker Carlson describing dramatic energy improvements, generated enormous organic reach. Whether those outcomes are reproducible in broader populations is an open clinical question.

What Does Gary Brecka Take and Recommend?

Brecka's publicly stated personal protocol, drawn from his podcast appearances and 10X Health marketing materials, includes the following elements. These are his stated positions, not HealthRX endorsements.

Methylated B-Vitamins and MTHFR Support

Brecka's central argument is that MTHFR (methylenetetrahydrofolate reductase) variants impair the conversion of dietary folate into the active form the body uses for DNA repair, neurotransmitter synthesis, and homocysteine clearance. He recommends bypassing the conversion step entirely with pre-methylated forms: methylfolate (5-MTHF) and methylcobalamin (methyl-B12) rather than folic acid or cyanocobalamin.

This underlying biochemistry is not fringe. The MTHFR C677T variant does reduce enzyme activity by roughly 35% in heterozygotes and 70% in homozygotes, according to data published in the American Journal of Human Genetics [1]. Elevated homocysteine is a recognized cardiovascular risk marker; the American Heart Association notes that high homocysteine is associated with increased coronary artery disease risk, though B-vitamin supplementation trials have not consistently translated homocysteine lowering into reduced clinical events [2].

Brecka's extrapolation from variant presence to dramatic disease causation goes further than the current evidence supports. A heterozygous C677T carrier does not automatically have pathological homocysteine levels.

Hyperbaric Oxygen Therapy (HBOT)

Brecka has promoted HBOT extensively for longevity, cognitive function, and recovery. He uses a hard-shell chamber at 1.5 to 2.0 atmospheres of absolute pressure (ATA) with 100% oxygen.

The most cited study in longevity-focused HBOT discussions is the 2020 Shai Efrati trial from Tel Aviv University (N=35 healthy adults aged 64 and older). After 60 sessions of HBOT at 2.0 ATA, researchers observed a mean 20.3% increase in telomere length and a 37% reduction in senescent T-helper cells [3]. The authors noted these were the first results showing that a non-pharmacological intervention could reverse telomere shortening. The sample size is small and the trial was not blinded, which limits generalizability.

The FDA has cleared HBOT for 14 specific indications, including diabetic foot wounds, carbon monoxide poisoning, and radiation tissue injury. Longevity and anti-aging are not among them [4].

Hydrogen-Rich Water

Brecka has called hydrogen water one of his daily non-negotiables. Molecular hydrogen (H2) acts as a selective antioxidant. A 2020 systematic review in Antioxidants (MDPI) covering 25 human trials found that hydrogen-rich water reduced markers of oxidative stress, including malondialdehyde, in multiple disease contexts, though the authors acknowledged that optimal dosing protocols remain undefined [5].

Grounding, Breathwork, and Cold Exposure

Brecka also advocates earthing (direct skin contact with the ground), Wim Hof-style breathwork, and cold-water immersion. Evidence for each exists on a spectrum. Cold-water immersion at 11 to 15°C for roughly 11 minutes per week has been associated with norepinephrine increases of up to 300% in human subjects in work published in Cell Reports Medicine in 2022 [6]. Grounding's mechanistic claims rest on thinner evidence.

The MTHFR Methylation Framework: What the Science Actually Says

Methylation is a core biochemical process in which a methyl group (CH3) attaches to DNA, proteins, or small molecules to regulate gene expression, synthesize neurotransmitters, and clear homocysteine from the blood. Brecka's framework treats impaired methylation as a master upstream defect. Here is how that maps onto established literature.

MTHFR Variants: Prevalence and Real Clinical Impact

The C677T and A1298C are the two most studied MTHFR SNPs. C677T homozygosity (TT genotype) affects approximately 10 to 15% of people of European ancestry and correlates with plasma homocysteine levels roughly 25% higher than those with the CC genotype, per a meta-analysis of 7,755 subjects in Arteriosclerosis, Thrombosis, and Vascular Biology [7].

Homocysteine above 15 micromol/L is generally considered hyperhomocysteinemia. Whether treating it pharmacologically improves hard clinical endpoints remains debated. The VISP trial (N=3,680) found that high-dose B-vitamin supplementation lowered homocysteine but did not reduce the risk of recurrent stroke at two years [8].

This does not mean methylated B-vitamins are without benefit. For individuals with documented deficiencies in B12 or folate, correcting those deficiencies has well-established clinical value. The gap between Brecka's claims and the evidence is in the magnitude of benefit he attributes to these interventions in people who are not frankly deficient.

What a Physician-Ordered Methylation Workup Looks Like

A standard methylation-relevant lab panel ordered through a licensed physician would include:

• Serum homocysteine (reference range: 5 to 15 micromol/L)
• Serum folate and RBC folate
• Serum B12 (methylcobalamin preferred for repletion if deficient)
• Complete blood count with differential (to detect megaloblastic changes)
• MTHFR C677T and A1298C genotyping

Most of these are covered by insurance when ordered for clinical indications. Direct-access labs such as LabCorp and Quest Diagnostics offer the MTHFR genotype panel for $100, $250 without insurance. A physician interprets results in context before any supplementation protocol is initiated.

How a Regular Patient Gets Access to These Protocols

This is the practical question most people arrive at after watching a Brecka interview. The honest answer is that nearly every element of his protocol is accessible outside of 10X Health, often through primary care, telehealth, or outpatient specialty centers.

Step 1: Start With Lab Work, Not Supplements

The most common mistake after watching a Brecka video is buying a methylfolate supplement before knowing whether methylation is actually impaired. A regular patient's first move should be a physician-ordered lab panel covering the markers above. Many telehealth platforms, including HealthRX, order these panels with a licensed clinician review included in the consult fee.

Step 2: Genetic Testing Through a Clinical-Grade Lab

Brecka's 10X Health Gene Mutation Panel is a proprietary product. Clinically equivalent MTHFR genotyping is available through:

• LabCorp (MTHFR C677T and A1298C, CPT 81291)
• Quest Diagnostics (MTHFR mutation analysis)
• Invitae or GeneDx for broader cardiovascular genomics panels

Consumer platforms like 23andMe also report C677T and A1298C, though raw data requires third-party interpretation tools and should be reviewed by a clinician before clinical decisions are made.

Step 3: Hyperbaric Oxygen Therapy Access

Hard-shell HBOT chambers operating at 1.5 to 2.0 ATA with 100% oxygen are available at:

• Hospital-based wound care centers (covered by Medicare and most insurers for approved indications)
• Outpatient HBOT clinics operating on a cash-pay or membership model ($150, $400 per session)
• Some integrative medicine practices

Soft-shell "mild HBOT" chambers sold for home use operate at 1.3 ATA with ambient air. These are not equivalent to the 2.0 ATA protocol used in the Efrati longevity trial [3] and should not be represented as such. A physician referral is advisable before beginning HBOT for any off-label application.

Step 4: Hydrogen Water Devices

Electrolytic hydrogen water generators produce water with dissolved H2 concentrations of 0.5 to 1.6 parts per million depending on the device. Consumer models range from $80 to $600. There is no licensed-physician requirement to purchase one, though the clinical context of use matters.

Step 5: Telehealth Longevity Panels

Several telehealth platforms now offer integrated longevity panels that bundle lab work, genetic interpretation, and physician consultation. A reasonable minimum panel for a longevity-focused patient includes:

• Complete metabolic panel
• Lipid panel with apolipoprotein B and Lp(a)
• HbA1c and fasting insulin
• Thyroid-stimulating hormone (TSH)
• Free and total testosterone (men), estradiol and FSH (women)
• DHEA-S, IGF-1
• High-sensitivity CRP
• Homocysteine
• 25-OH Vitamin D
• MTHFR genotyping

This type of panel gives a clinician the data needed to make individualized recommendations rather than applying a one-size protocol.

What the Longevity Medicine Field Says

Brecka operates at the intersection of legitimate longevity medicine and consumer marketing. The field itself, represented by organizations such as the American Academy of Anti-Aging Medicine and researchers publishing in journals like Aging Cell and Nature Aging, supports a data-driven, biomarker-guided approach. The gap is in rigor.

Peter Attia's Framework Versus Brecka's Approach

Physician and longevity researcher Peter Attia, M.D., has publicly described his approach as "Medicine 3.0," focused on extending the healthspan through lipid management, glucose control, strength training, and sleep optimization. In his book Outlive (2023), Attia writes: "The leading causes of death in people over 40 are heart disease, cancer, neurodegenerative disease, and type 2 diabetes. Virtually all of them have modifiable risk factors that current medicine addresses too late." His framework prioritizes Lp(a) testing, APOE genotyping for Alzheimer's risk stratification, and VO2 max improvement. Methylation optimization is not a centerpiece of his public protocol.

This contrast is not a dismissal of Brecka's work. It illustrates that legitimate longevity medicine is itself heterogeneous, and that patients benefit from understanding which claims rest on large RCT data versus mechanistic plausibility.

The Telomere Measurement Problem

Brecka and others cite telomere length as a longevity biomarker. The Efrati 2020 HBOT trial showed telomere lengthening, which generated significant media coverage. However, a 2023 editorial in Nature Aging noted that population-level telomere length has a genetic component accounting for roughly 70% of variance, meaning an individual's single-point telomere measurement is a weak predictor of personal longevity trajectory [9]. Serial measurements over years are more informative than a single baseline test.

Risks and Contraindications a Regular Patient Should Know

No intervention discussed here is without risk.

HBOT Risks

Absolute contraindications to HBOT include untreated pneumothorax and concurrent doxorubicin or bleomycin chemotherapy. Relative contraindications include uncontrolled seizure disorder, severe COPD with CO2 retention, and claustrophobia. Ear barotrauma is the most common adverse event, occurring in roughly 1 in 1,000 sessions at trained facilities [4].

Methylfolate Over-Supplementation

Some individuals, particularly those with certain psychiatric conditions, report worsening anxiety or mood instability when starting high-dose methylfolate. Starting at 400 mcg daily and titrating upward under physician supervision is preferable to beginning at the 15 mg doses sometimes suggested in influencer contexts.

Hydrogen Water

Molecular hydrogen appears safe at concentrations achievable through commercial devices. No serious adverse events have been reported in human trials to date [5].

Pricing Reality Check: 10X Health Versus Independent Access

| Protocol Element | 10X Health (Est.) | Independent Access | |---|---|---| | Gene Mutation Panel | $599, $799 (reported) | $100, $300 via LabCorp/Quest | | Supplement bundle | $150, $400/month | $30, $80/month for component ingredients | | HBOT (per session) | $200, $350 (South Florida clinic) | $150, $400 at any accredited outpatient center | | Physician consultation | Included in package | $75, $250 telehealth visit | | Hydrogen water device | $400, $600 (branded) | $80, $400 (unbranded equivalents) |

The data above are based on publicly reported pricing and typical U.S. Market rates as of mid-2025. Individual prices vary by location and provider.

HealthRX Clinical Perspective

Brecka has moved methylation biology and MTHFR awareness into mainstream conversation in a way that academic medicine has not managed. That is a genuine contribution. The risk is that patients interpret enthusiasm as evidence equivalency. A large mechanistic rationale does not substitute for a randomized controlled trial in a representative population.

A clinician-ordered lab panel costs less than a 10X Health package and produces the same genotype data. HBOT is available at accredited outpatient centers nationwide. Hydrogen water devices are a consumer purchase. None of these require a celebrity's brand as an intermediary.

The American Heart Association's 2021 scientific statement on dietary supplements and cardiovascular disease concluded that no supplement has sufficient evidence to warrant routine recommendation for primary prevention of CVD events [2]. That statement covers most of what Brecka's supplement stack targets. It does not mean the supplements are harmful or useless. It means the evidence bar for "you should definitely take this" has not yet been cleared by RCT data in the general population.

Patients who want to apply a systematic longevity approach should start with a full biomarker panel reviewed by a licensed physician, establish their actual baseline values, and then layer in interventions sequentially so that response can be attributed to a specific change. A 30-day washout between new interventions makes causality far easier to track.